OMRON Co. (OTCMKTS:OMRNY - Get Free Report)'s share price dropped 2% during mid-day trading on Thursday following a dissappointing earnings announcement. The company traded as low as $29.10 and last traded at $29.10. Approximately 24,977 shares traded hands during trading, a decline of 58% from the average daily volume of 59,365 shares. The stock had previously closed at $29.68.
The company reported $0.30 EPS for the quarter, missing analysts' consensus estimates of $0.41 by ($0.11). The company had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.48 billion. OMRON had a return on equity of 0.81% and a net margin of 0.98%.
Institutional Investors Weigh In On OMRON
An institutional investor recently raised its position in OMRON stock. GAMMA Investing LLC raised its stake in OMRON Co. (OTCMKTS:OMRNY - Free Report) by 831.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,946 shares of the company's stock after buying an additional 13,342 shares during the period. GAMMA Investing LLC's holdings in OMRON were worth $421,000 at the end of the most recent quarter. Institutional investors and hedge funds own 1.09% of the company's stock.
OMRON Trading Up 0.5%
The firm has a 50-day moving average of $29.18 and a 200-day moving average of $31.58. The firm has a market capitalization of $5.90 billion, a P/E ratio of 105.93 and a beta of 1.14. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.45 and a current ratio of 2.20.
OMRON Company Profile
(
Get Free Report)
OMRON Corporation engages in industrial automation, device and module solutions, social systems, and healthcare businesses worldwide. The Industrial Automation Business offers sensors, switches, safety and control components, relays, motion and drives, robotics, energy conservation, power supplies, and automation system products.
Featured Articles
Before you consider OMRON, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OMRON wasn't on the list.
While OMRON currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
